Tender detail
Open-house pharmaceutical discount agreements for perindopril, amlodipine and indapamide
Summary
AOK Bayern intends to conclude non-exclusive pharmaceutical discount agreements with all interested pharmaceutical companies for medicines containing perindopril, amlodipine and indapamide (ATC C09BX01). The agreements are scheduled to run from 1 January 2027 to 31 December 2028, with companies able to join until 3 November 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.